G642-1931 Screening compound: 2-({4-acetyl-5-[4-(benzyloxy)-3-methoxyphenyl]-4,5-dihydro-1,3,4-oxadiazol-2-yl}methoxy)-5-bromo-4-(methoxymethyl)-6-methylpyridine-3-carbonitrile

G642-1931 Screening compound: 2-({4-acetyl-5-[4-(benzyloxy)-3-methoxyphenyl]-4,5-dihydro-1,3,4-oxadiazol-2-yl}methoxy)-5-bromo-4-(methoxymethyl)-6-methylpyridine-3-carbonitrile
G642-1931 Screening compound: 2-({4-acetyl-5-[4-(benzyloxy)-3-methoxyphenyl]-4,5-dihydro-1,3,4-oxadiazol-2-yl}methoxy)-5-bromo-4-(methoxymethyl)-6-methylpyridine-3-carbonitrile alternative view

Chemical Structure Depiction of ChemDiv screening compound G642-1931
2-({4-acetyl-5-[4-(benzyloxy)-3-methoxyphenyl]-4,5-dihydro-1,3,4-oxadiazol-2-yl}methoxy)-5-bromo-4-(methoxymethyl)-6-methylpyridine-3-carbonitrile

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G642-1931

Molecular Formula

C28H27BrN4O6 (C28 H27 BrN4 O6)

Compound Name

2-({4-acetyl-5-[4-(benzyloxy)-3-methoxyphenyl]-4,5-dihydro-1,3,4-oxadiazol-2-yl}methoxy)-5-bromo-4-(methoxymethyl)-6-methylpyridine-3-carbonitrile

IUPAC name

2-({4-acetyl-5-[4-(benzyloxy)-3-methoxyphenyl]-45-dihydro-134-oxadiazol-2-yl}methoxy)-5-bromo-4-(methoxymethyl)-6-methylpyridine-3-carbonitrile

SMILES

CC(N1N=C(COc(nc(C)c(Br)c2COC)c2C#N)OC1c(cc1)cc(OC)c1OCc1ccccc1)=O

InChI

InChI=1S/C28H27BrN4O6/c1-17-26(29)22(15-35-3)21(13-30)27(31-17)38-16-25-32-33(18(2)34)28(39-25)20-10-11-23(24(12-20)36-4)37-14-19-8-6-5-7-9-19/h5-12,28H,14-16H2,1-4H3/t28-/m1/s1

InChI Key

CPLJSFRUASKIEN-MUUNZHRXSA-N

MDL Number (MFCD)

MFCD15025332

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

595.45

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

4.563

Distribution Coefficient, logD

4.563

Water Solubility, LogSw

-4.91

Polar Surface Area

93.271

Acid Dissociation Constant (pKa)

23.60

Base Dissociation Constant (pKb)

0.17

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.60

G642-1931 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with G642-1931 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G642-1931?
Check Price and Availability of G642-1931, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G642-1931 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G642-1931
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G642-1931
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G642-1931 available by request